Effect of green tea consumption on blood pressure: a meta-analysis of 13 randomized controlled trials.

PubWeight™: 0.81‹?›

🔗 View Article (PMC 4150247)

Published in Sci Rep on September 01, 2014

Authors

Xiaoli Peng1, Rui Zhou2, Bin Wang3, Xiaoping Yu4, Xiaohong Yang4, Kai Liu3, Mantian Mi3

Author Affiliations

1: 1] Department of Epidemiology and Health Statistics, Institute of Public Health, Chengdu Medical College, Chengdu 610083, Sichuan, China [2] Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Third Military Medical University, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Medical Nutrition Research Center, Chongqing 400038, China [3].
2: 1] Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Third Military Medical University, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Medical Nutrition Research Center, Chongqing 400038, China [2].
3: Research Center for Nutrition and Food Safety, Institute of Military Preventive Medicine, Third Military Medical University, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Medical Nutrition Research Center, Chongqing 400038, China.
4: Department of Epidemiology and Health Statistics, Institute of Public Health, Chengdu Medical College, Chengdu 610083, Sichuan, China.

Articles cited by this

Measuring inconsistency in meta-analyses. BMJ (2003) 128.20

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA (2014) 34.12

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet (1998) 19.31

Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA (2002) 6.84

Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res (2007) 5.60

Beneficial effects of green tea--a review. J Am Coll Nutr (2006) 4.76

Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol (1992) 4.72

Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA (2006) 4.08

Sample size calculations for randomized controlled trials. Epidemiol Rev (2002) 3.22

Tea polyphenols for health promotion. Life Sci (2007) 2.50

Coffee, caffeine, and cardiovascular disease in men. N Engl J Med (1990) 2.49

The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. J Am Coll Cardiol (2012) 2.44

Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr (2003) 2.17

Green tea catechins and cardiovascular health: an update. Curr Med Chem (2008) 1.58

Coffee intake and risk of hypertension: the Johns Hopkins precursors study. Arch Intern Med (2002) 1.58

EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab (2007) 1.58

(-)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB. Mol Pharmacol (1997) 1.55

A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring) (2007) 1.50

Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J Hypertens (2005) 1.43

Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr (2010) 1.31

Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr (2008) 1.28

Physiology of the endothelium. Br J Anaesth (2004) 1.25

Green tea extract reduces blood pressure, inflammatory biomarkers, and oxidative stress and improves parameters associated with insulin resistance in obese, hypertensive patients. Nutr Res (2012) 1.23

Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol (Tokyo) (2005) 1.17

A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes. Obesity (Silver Spring) (2008) 1.10

Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr (2004) 1.08

Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr (2011) 1.08

Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr (2011) 1.06

A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol (2001) 1.06

Tea is the major source of flavan-3-ol and flavonol in the U.S. diet. J Nutr (2008) 1.06

Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr (2007) 1.05

CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med (2011) 1.04

Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res (2012) 1.03

Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr (2007) 0.98

Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev (2013) 0.96

Green tea catechins: defensive role in cardiovascular disorders. Chin J Nat Med (2013) 0.96

Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition (2008) 0.95

Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr (2013) 0.95

Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr (2011) 0.94

Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. J Nutr (2008) 0.90

Metabolic effects of green tea and of phases of weight loss. Physiol Behav (2005) 0.89

The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis (2014) 0.86

Effect of green tea extract (catechins) in reducing oxidative stress seen in patients of pulmonary tuberculosis on DOTS Cat I regimen. Phytomedicine (2009) 0.85

Preventive effects of green tea catechins on spontaneous stroke in rats. Med Sci Monit (2007) 0.82

Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr (2014) 0.81

Controlling hypertension from a public health perspective. Int J Cardiol (2008) 0.76